Literature DB >> 2943901

The homeostasis of calcium in heart cells.

E Carafoli.   

Abstract

The signalling function of Ca2+ demands a very low ionic concentration of the cation within heart cells. This is achieved by two mechanisms, the reversible complexation of calcium by non membranous (protein) ligands, and its binding and transport by transmembrane proteins. The second mechanism is more efficient, since the complexation by soluble proteins is limited by their amount in heart sarcoplasm or within heart organelles, whereas membrane proteins can regulate calcium efficiently, even if present in low amounts, if they 'return' rapidly in the uncomplexed from after each binding and transport cycle. Seven systems for the transport of calcium have been documented in heart membranes. There are located in sarcolemma, two in mitochondria, two in sarcoplasmic reticulum. These seven systems can be simplified to four basic transport modes: ATPases, Na+/Ca2+ exchangers, channels, electrophoretic uniporters. They have either low or high calcium affinity, thus serving different purposes in the various phases of the functional cycle of heart cells. On an integrated level, sarcoplasmic reticulum can be considered as the organelle presiding over the rapid and fine regulation of Ca2+ linked to the contraction/relaxation cycle. Sarcolemma regulates Ca2+ with both low and high affinity, but handles a quantitatively minor amount of Ca2+ (trigger Ca2+). Mitochondria are low-affinity organelles, whose primary role probably is the regulation of Ca2+ in their matrix, rather than in the sarcoplasm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2943901     DOI: 10.1016/s0022-2828(85)80003-1

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  43 in total

1.  Paradoxical block of the Na+-Ca2+ exchanger by extracellular protons in guinea-pig ventricular myocytes.

Authors:  M Egger; E Niggli
Journal:  J Physiol       Date:  2000-03-01       Impact factor: 5.182

2.  Compensatory up-regulation of cardiac SR Ca2+-pump by heat-shock counteracts SR Ca2+-channel activation by ischemia/reperfusion.

Authors:  P J O'Brien; G O Li; M Locke; R E Klabunde; C D Ianuzzo
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

Review 3.  Myocardial fatty acid oxidation during ischemia and reperfusion.

Authors:  R Lerch; C Tamm; I Papageorgiou; R H Benzi
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

Review 4.  Mechanisms of exercise-induced muscle fibre injury.

Authors:  R B Armstrong; G L Warren; J A Warren
Journal:  Sports Med       Date:  1991-09       Impact factor: 11.136

5.  Effects of the divalent cation ionophore ionomycin on the performance of isolated guinea-pig atria.

Authors:  H M Himmel; R Riehle; K Stieler; M Siess
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

Review 6.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

7.  Interaction of intracellular ion buffering with transmembrane-coupled ion transport.

Authors:  R P Kline; L Zablow; I S Cohen
Journal:  J Gen Physiol       Date:  1990-03       Impact factor: 4.086

8.  The cardioplegic solution HTK: effects on membrane potential, intracellular K+ and Na+ activities in sheep cardiac Purkinje fibres.

Authors:  E Krohn; B Stinner; M Fleckenstein; M M Gebhard; H J Bretschneider
Journal:  Pflugers Arch       Date:  1989-12       Impact factor: 3.657

9.  The energy expenditure of actomyosin-ATPase, Ca(2+)-ATPase and Na+,K(+)-ATPase in guinea-pig cardiac ventricular muscle.

Authors:  M Schramm; H G Klieber; J Daut
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

10.  Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.

Authors:  E A Bernstein; F R Eberli; A M Silverman; G L Horowitz; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.